Products / Life Sciences
Microarray
Research to Diagnosis, Your Power in Microarray
Microarray technologies form the basis of modern genomic analysis by enabling the precise detection of genetic variations and epigenetic changes.
They offer effective and cost-efficient solutions for analysing structural variants such as CNVs, deletions, and duplications, as well as epigenetic profiles such as DNA methylation.
Discover Your Power in Microarray with iScan
The Illumina iScan System is a platform optimised for genome-wide variant analysis, epigenetic screening, pharmacogenetic applications, and more.
With its high sample processing capacity and precise reading capability, it supports reliable data production in laboratories.
Perform a Deep Screening Your Cytogenetic Analysis
Illumina Infinium™ Global Screening Array with Cytogenetics enables high-sensitivity analysis of structural variants such as chromosomal imbalances, deletions and duplications.
This solution, specifically optimised for clinical cytogenetic applications, enhances diagnostic reliability with genome-wide CNV and LoH detection.
Find Solutions That Are Tailored for Your Needs with
Global Diversity Array.
- Focused on capturing ethnic diversity in order to accelerate disease research and treatments.
- Designed for discovery and polygenic risk score development in multi-ethnic and mixed populations.
- Includes the updated content of the ACMG 59 panel and the structural variants defined by Audano et al. (2019).
- Includes enhanced exome coverage for the identification of high-impact variants.
- Current clinical research and quality control content is available for screening and sample tracking.
- It contains Carrier Screening (CS) and Polygenic Risk Score (PRS) arrays specifically designed for the GDA backbone.
Global Diversity Array
Prevent Risks with Expanded Carrier Screening
- Includes 45,000 variants specific to carrier screening covering 602 genes.
- Provides 97% coverage for diseases occurring at a frequency of 1/200 or higher.
- Includes all ACMG recommended tier 1-3 carrier genes (except FMR1 and FXN).
- Identifies both sequence and structural variants by integrating different workflows into a single analysis.
Stay Ahead with Polygenic Risk Score Analysis
The polygenic risk score (PRS) is an estimate of an individual’s genetic susceptibility to a trait or disease, calculated based on their genotype profile and relevant genome-wide association study (GWAS) data.
PRS calculation is performed using panels containing different numbers of single-nucleotide polymorphisms (SNPs). For each SNP, the sum of risk alleles is calculated by weighting them with the corresponding effect size.
SNPs and their corresponding effect sizes are obtained from the largest GWAS available for the relevant disease.
A versatile, scalable platform for multi-ethnic PRS research
- 1.3 Million SNP backbone with 160K PRS Markers
- Highly accurate, pan-ethnic PRS estimation
- Predict for automated analysis
- Analysis of over 20 traits in a single study
Meet the Gold Standard in DNA Methylation Analysis
The Illumina Infinium MethylationEPIC BeadChip provides comprehensive DNA methylation profiling for a wide range of biomarkers, from cancer to immune disorders.
It is widely preferred in clinical research.